Table 1.
Patients demographic, clinical and metabolic characteristics
| Total number of patients | 501 |
| Gender (male/female) | 277/224 |
| Age (years) | 60.4 ± 8.1 |
| Diabetes duration (years) | 9.9 ± 6.9 |
| Body mass index (kg/m2) | 30.4 ± 4.8 |
| Systolic blood pressure (mmHg) | 136.7 ± 48.7 |
| Diastolic blood pressure (mmHg) | 80.8 ± 7.0 |
| Coronary heart disease (%) | 22.9 |
| Stroke (%) | 6.8 |
| Retinopathy (%) | 47.5 |
| Polyneuropathy (%) | 74.5 |
| Metformin (%) | 77.2 |
| Sulphonylurea (%) | 38.5 |
| Insulin (%) | 69.1 |
| Fasting glucose (mmol/l) | 8.9 ± 2.9 |
| Mean postprandial glucose (mmol/l) | 10.4 ± 3.5 |
| Mean blood glucose (mmol/l) | 9.3 ± 3.0 |
| MAGE (mmol/l) | 4.1 ± 2.1 |
| HbA1c (%) | 8.1 ± 1.4 |
| Total cholesterol (mmol/l) | 5.8 ± 1.5 |
| Triglycerides (mmol/l) | 2.1 ± 1.6 |
| eGFR (ml/min/1.73 m2) | 96.4 ± 22.7 |
MAGE mean amplitude of glycaemic excursion, eGFR estimated glomerular filtration rate